These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34270619)

  • 1. Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    Kirilmaz OB; Salegaonkar AR; Shiau J; Uzun G; Ko HS; Lee HF; Park S; Kwon G
    PLoS One; 2021; 16(7):e0254718. PubMed ID: 34270619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural network-based model predictive control for type 1 diabetic rats on artificial pancreas system.
    Bahremand S; Ko HS; Balouchzadeh R; Felix Lee H; Park S; Kwon G
    Med Biol Eng Comput; 2019 Jan; 57(1):177-191. PubMed ID: 30069675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

  • 4. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
    Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
    Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camel milk ameliorates hyperglycaemia and oxidative damage in type-1 diabetic experimental rats.
    Meena S; Rajput YS; Pandey AK; Sharma R; Singh R
    J Dairy Res; 2016 Aug; 83(3):412-9. PubMed ID: 27600979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study.
    Lee MH; Vogrin S; Paldus B; Jones HM; Obeyesekere V; Sims C; Wyatt SA; Ward GM; McAuley SA; MacIsaac RJ; Krishnamurthy B; Sundararajan V; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Sep; 21(9):499-506. PubMed ID: 31264889
    [No Abstract]   [Full Text] [Related]  

  • 9. A bio-inspired glucose controller based on pancreatic β-cell physiology.
    Herrero P; Georgiou P; Oliver N; Johnston DG; Toumazou C
    J Diabetes Sci Technol; 2012 May; 6(3):606-16. PubMed ID: 22768892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
    Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
    Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of MiniMed 640G with SmartGuard® System for prevention of hypoglycemia in pediatric patients with type 1 diabetes mellitus.
    Villafuerte Quispe B; Martín Frías M; Roldán Martín MB; Yelmo Valverde R; Álvarez Gómez MÁ; Barrio Castellanos R
    Endocrinol Diabetes Nutr; 2017 Apr; 64(4):198-203. PubMed ID: 28417874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.
    Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Obes Metab; 2017 May; 19(5):713-720. PubMed ID: 28094472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats.
    Babukumar S; Vinothkumar V; Sankaranarayanan C; Srinivasan S
    Pharm Biol; 2017 Dec; 55(1):1442-1449. PubMed ID: 28330423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
    Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
    Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement.
    Turksoy K; Bayrak ES; Quinn L; Littlejohn E; Cinar A
    Diabetes Technol Ther; 2013 May; 15(5):386-400. PubMed ID: 23544672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes.
    Breton MD; Kanapka LG; Beck RW; Ekhlaspour L; Forlenza GP; Cengiz E; Schoelwer M; Ruedy KJ; Jost E; Carria L; Emory E; Hsu LJ; Oliveri M; Kollman CC; Dokken BB; Weinzimer SA; DeBoer MD; Buckingham BA; Cherñavvsky D; Wadwa RP;
    N Engl J Med; 2020 Aug; 383(9):836-845. PubMed ID: 32846062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
    Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
    Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes.
    Viñals C; Beneyto A; Martín-SanJosé JF; Furió-Novejarque C; Bertachi A; Bondia J; Vehi J; Conget I; Giménez M
    J Clin Endocrinol Metab; 2021 Jan; 106(1):55-63. PubMed ID: 32852548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.